These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 34643225)
1. Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome. Straub L; Huybrechts KF; Hernández-Díaz S; Zhu Y; Vine S; Desai RJ; Gray KJ; Bateman BT Am J Epidemiol; 2022 Jan; 191(1):208-219. PubMed ID: 34643225 [TBL] [Abstract][Full Text] [Related]
2. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT BMJ; 2015 May; 350():h2102. PubMed ID: 25975601 [TBL] [Abstract][Full Text] [Related]
3. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018. Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554 [No Abstract] [Full Text] [Related]
4. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023 [TBL] [Abstract][Full Text] [Related]
5. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628 [No Abstract] [Full Text] [Related]
6. Maternal prepregnancy surgery and risk of neonatal abstinence syndrome in future newborns: a longitudinal cohort study. Auger N; Low N; Carrier FM; Ayoub A; Luu TM CMAJ; 2019 Jul; 191(28):E779-E786. PubMed ID: 31308006 [TBL] [Abstract][Full Text] [Related]
7. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida. Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694 [TBL] [Abstract][Full Text] [Related]
8. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312 [TBL] [Abstract][Full Text] [Related]
11. A Practical Approach to Neonatal Opiate Withdrawal Syndrome. Devlin LA; Davis JM Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261 [TBL] [Abstract][Full Text] [Related]
12. Opioids affect the fetal brain: reframing the detoxification debate. Caritis SN; Panigrahy A Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015. Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913 [TBL] [Abstract][Full Text] [Related]
14. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome. Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391 [TBL] [Abstract][Full Text] [Related]
15. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care. Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819 [TBL] [Abstract][Full Text] [Related]
17. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors. Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611 [TBL] [Abstract][Full Text] [Related]
18. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics. Schwartz AN; Meschke LL Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341 [TBL] [Abstract][Full Text] [Related]
19. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome. Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome. Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]